Market changes are driving pharmaceutical companies to consider new ways to mitigate risk in the cold chain.
Dirk Van Peteghem
Advertisement
Articles by Dirk Van Peteghem
Advertisement
Latest Updated Articles
Reinventing the Cold Chain in a High-Stakes MarketPublished: March 1st 2015 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
